mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
simvastatin |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
Vorinostat |
gCSI |
pan-cancer |
AAC |
-0.16 |
0.002 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.15 |
0.004 |
mRNA |
NSC632839 |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.005 |
mRNA |
GW843682X |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.006 |
mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
-0.27 |
0.009 |
mRNA |
KHS101 |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.009 |
mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.01 |